Part 1 – Patents, Trademarks and Other IP Protections and Mechanisms
Donna M. Meuth
Associate General Counsel, Intellectual Property
Eisai Inc. (Andover, MA)
Jill K. MacAlpine, Ph.D.
Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP (Washington, DC)
- Summarizing the patenting process for drugs and biologics
- Strategies for building patent protection drugs and biologics
- Seeking extension of patent term for time spent in the drug approval process (Patent Term Extension, Supplemental Protection Certificates), and/or time spent obtaining a patent at the United States Patent Office (Patent Term Adjustment)
- 271(e)(1) “safe harbor”
- Identifying the respective roles of the FDA and the PTO in the patenting of drugs and biological products
- Determining whether to seek a trademark or a patent for a product